[go: up one dir, main page]

BR9813465A - Polissacarìdeos modificados que exibem reconhecimento biológico alterado - Google Patents

Polissacarìdeos modificados que exibem reconhecimento biológico alterado

Info

Publication number
BR9813465A
BR9813465A BR9813465-5A BR9813465A BR9813465A BR 9813465 A BR9813465 A BR 9813465A BR 9813465 A BR9813465 A BR 9813465A BR 9813465 A BR9813465 A BR 9813465A
Authority
BR
Brazil
Prior art keywords
altered biological
modified polysaccharides
biological recognition
exhibit altered
polysaccharides
Prior art date
Application number
BR9813465-5A
Other languages
English (en)
Inventor
Bo E Hedlund
Thomas P Weber
Paul R Dragsten
Gregory J Hanson
Philip E Hallaway
Original Assignee
Biomed Frontiers Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomed Frontiers Inc filed Critical Biomed Frontiers Inc
Publication of BR9813465A publication Critical patent/BR9813465A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/547—Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/18—Oxidised starch
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/18—Oxidised starch
    • C08B31/185—Derivatives of oxidised starch, e.g. crosslinked oxidised starch

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Patente de Invenção: "POLISSACARìDEOS MODIFICADOS QUE EXIBEM RECONHECIMENTO BIOLóGICO ALTERADO". A invenção refere-se a polissacarídeos, conjugados de polissacarídeos com propriedades biológicas alteradas, e a métodos para produzir estes polissacarídeos e conjugados.
BR9813465-5A 1997-12-09 1998-12-09 Polissacarìdeos modificados que exibem reconhecimento biológico alterado BR9813465A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6907997P 1997-12-09 1997-12-09
US6909597P 1997-12-11 1997-12-11
PCT/US1998/026132 WO1999029328A1 (en) 1997-12-09 1998-12-09 Modified polysaccharides exhibiting altered biological recognition

Publications (1)

Publication Number Publication Date
BR9813465A true BR9813465A (pt) 2002-01-22

Family

ID=26749664

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9813465-5A BR9813465A (pt) 1997-12-09 1998-12-09 Polissacarìdeos modificados que exibem reconhecimento biológico alterado

Country Status (12)

Country Link
US (1) US6479468B1 (pt)
EP (1) EP1037642B9 (pt)
JP (1) JP4435412B2 (pt)
AT (1) ATE425758T1 (pt)
AU (1) AU761784B2 (pt)
BR (1) BR9813465A (pt)
CA (1) CA2314716C (pt)
DE (1) DE69840673D1 (pt)
DK (1) DK1037642T3 (pt)
ES (1) ES2325005T3 (pt)
TR (1) TR200001682T2 (pt)
WO (1) WO1999029328A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780852B2 (en) 1997-12-09 2004-08-24 Bo E. Hedlund Modified polysaccharides exhibiting altered biological recognition
US20030236224A1 (en) * 1997-12-09 2003-12-25 Hedlund Bo E. Modified polysaccharides exhibiting altered biological recognition
AU2001296915A1 (en) 2000-09-26 2002-04-08 Sidney Kimmel Cancer Center Inhibition of antigen presentation with poorly catabolized polymers
EP1707632A1 (de) * 2005-04-01 2006-10-04 Bayer CropScience GmbH Phosphorylierte waxy-Kartoffelstärke
US7709001B2 (en) * 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
BR112012009014B8 (pt) 2009-09-30 2022-10-04 Novartis Ag Processo para preparar conjugado de polissacarídeo capsular de s. aureus tipo 5 ou tipo 8 e molécula de transporte crm197, conjugado e composição imunogênica
WO2017075055A1 (en) 2015-10-26 2017-05-04 President And Fellows Of Harvard College Reduced and oxidized polysaccharides and methods of use thereof
WO2018229117A1 (en) * 2017-06-13 2018-12-20 Merz Pharma Gmbh & Co. Kgaa Mixing nozzle, application device, kit and method using the mixing nozzle or application device
EP3648593A1 (en) * 2017-07-06 2020-05-13 Bayer Aktiengesellschaft A weed control apparatus

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH406175A (de) * 1959-12-23 1966-01-31 Chugai Pharmaceutical Co Ltd Verfahren zur Herstellung eines Reduktionsproduktes von oxydierter Stärke
NL270107A (pt) 1960-10-11 1964-07-10
JPS5634701A (en) * 1979-08-29 1981-04-07 Meito Sangyo Kk Beta-1,3-glucan, its preparation and use
US4419365A (en) 1981-12-21 1983-12-06 Ciba-Geigy Corporation Method of treating Alzheimer's disease
US5217998A (en) * 1985-07-02 1993-06-08 Biomedical Frontiers, Inc. Composition for the stabilization of deferoxamine to chelate free ions in physiological fluid
US4863964A (en) * 1985-07-02 1989-09-05 Biomedical Frontiers, Inc. Method for the stabilization of deferoxamine to chelate free ions in physiological fluid
US4863961A (en) * 1985-11-25 1989-09-05 G. D. Searle & Co. Tetraenyl prostaglandins
US4987253A (en) 1988-09-19 1991-01-22 University Of Florida Method for the synthesis of desferrioxamine B and analogs thereof
US5268165A (en) 1990-10-16 1993-12-07 Biomedical Frontiers, Inc. Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging
US5493053A (en) 1994-12-21 1996-02-20 University Of Florida Research Foundation, Inc. Method for preparing desferrioxamine B and homologs thereof
US5811510A (en) * 1995-04-14 1998-09-22 General Hospital Corporation Biodegradable polyacetal polymers and methods for their formation and use
US5847110A (en) 1997-08-15 1998-12-08 Biomedical Frontiers, Inc. Method of reducing a schiff base

Also Published As

Publication number Publication date
AU761784B2 (en) 2003-06-12
DK1037642T3 (da) 2009-07-06
CA2314716C (en) 2009-02-03
EP1037642B9 (en) 2010-10-13
ES2325005T3 (es) 2009-08-21
US6479468B1 (en) 2002-11-12
ATE425758T1 (de) 2009-04-15
JP4435412B2 (ja) 2010-03-17
AU1719799A (en) 1999-06-28
DE69840673D1 (de) 2009-04-30
TR200001682T2 (tr) 2001-02-21
JP2001525369A (ja) 2001-12-11
EP1037642A1 (en) 2000-09-27
EP1037642B1 (en) 2009-03-18
WO1999029328A1 (en) 1999-06-17
CA2314716A1 (en) 1999-06-17

Similar Documents

Publication Publication Date Title
ES2182906T3 (es) Grapa quirurgica helicoidal.
ES2124668B1 (es) "nuevosl-arilpirazoles con propiedades plaguicidas.
DE69830326D1 (de) Iminbildende polysaccharide, deren herstellung und verwendung als zusatzmittel und immunstimulierende mittel
HN1996000017A (es) Isotiazolonas
ES2110386T1 (es) Conjugados de interferon.
DE69822957D1 (de) Hitzehärtbare Polysaccharide
ATE259830T1 (de) Polymerkomplexe von glukuronoglukanen
CY1114197T1 (el) Μεθοδος διαμορφωσης της δραστικοτητας λειτουργικων ανοσομοριων
ATE320771T1 (de) Flachdrahtstent
ID23374A (id) Halogenopirimidin
ES2151277T3 (es) Composiciones que comprenden conjugados de acido cis-docosahexaenoico y taxotere.
BR0015611A (pt) Processo de limpeza que utiliza ondas ultra-sÈnicas
DE60113445D1 (de) Substanzen mit verzweigten linkermolekülen
BR9813465A (pt) Polissacarìdeos modificados que exibem reconhecimento biológico alterado
BR9907025B1 (pt) Polissacarídeos sintéticos e uso dos mesmos
DE60037510D1 (de) Modifizierte polysaccharide mit amphiphilen einheiten
ATE246206T1 (de) Kollagenfreie kosmetische zubereitungen
BR0013221A (pt) Chá preto de folha
BG100248A (bg) Инхибитори на скваленсинтетаза
PT1143917E (pt) Derivados anticonvulsionantes uteis no tratamento da perturbacao de stress pos-traumatico
ES2196802T3 (es) Lactatos de citronelilo y/o de dihidrocitronelilo, su preparacion y su utilizacion.
ATE298373T1 (de) Immunstimulierende phellinus ssp. polysaccharid und verwendung
EP1127062A4 (en) Lymphoma associated molecules and uses therefor
ES2183947T3 (es) Mutantes que producen un potencializador de la actividad pesticida de un bacillus.
TR200103662T2 (tr) Yeni kalpainler ve bunların kullanılması

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO, POI A MATERIA REIVINDICADA NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA ART. 8O E 13 AD LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: C08B 37/02 (2006.01), A61K 31/718 (2006.0